ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
奥尔巴尼
21.74
0.0000
成交量:
- -
成交额:
- -
市值:
9.33亿
市盈率:
-12.08
高:
21.74
开:
21.74
低:
21.74
收:
21.74
数据加载中...
总览
公司
新闻
公告
公司资料
公司名字:
奥尔巴尼
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
http://www.amriglobal.com
邮编:
- -
电话:
- -
传真:
- -
简介:
Albany Molecular Research, Inc.于1991年6月20日成立于特拉华州,是一家全球性的合同化研究制造组织。公司为客户提供全面整合的药物发明、开发、制造服务。AMRI提供广泛的服务和技术支持,包括医药产品的研发、现有和试验新药的原料药和成品药的生产。在美国、欧洲、亚洲均有分部,AMRI保持了和客户在地理上的密切接触以及灵活多变的成本模式。AMRI也历史性的利用其药物开发专业技术施行数个内部药物开发项目,这些项目已经进入候选研发状态,有一些甚至进入了第一期临床研发状态。AMRI已经成功完成一些项目的合作计划,并正在积极寻求与战略伙伴就剩余项目的对外授权事项做进一步发展。公司提供科学的服务、技术以及产品,致力于提高生活质量。公司核心业务为有包括药物研发、生产的合同服务费用平台。公司还拥有一系列从内部项目产生的专有技术,包括药物研发、小众市场产品和制造工艺效率改进,其中一些授权给第三方,有益于公司运作。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/AMRI/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMRI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMRI\",,,,,undefined,":{"symbol":"AMRI","market":"US","secType":"STK","nameCN":"奥尔巴尼","latestPrice":21.74,"timestamp":1515186000000,"preClose":21.74,"halted":0,"volume":0,"delay":0,"floatShares":18650000,"shares":42932000,"eps":-1.8,"marketStatus":"已收盘","change":0,"latestTime":"01-05 16:00:00 EST","open":21.74,"high":21.74,"low":21.74,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.8,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1753171200000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":918104400000,"exchange":"NASDAQ","adjPreClose":21.74,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMRI\",,,,,undefined,":{"symbol":"AMRI","floatShares":18650000,"roa":"--","roe":"--","lyrEps":0,"shares":42932000,"dividePrice":0,"high":21.74,"amplitude":0,"preClose":21.74,"low":21.74,"week52Low":13.01,"pbRate":"2.94","week52High":22.17,"institutionHeld":0.9503,"latestPrice":21.74,"eps":-1.8,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.8,"open":21.74,"prevYearClose":21.74},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.amriglobal.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":0.0504},{"period":"3month","weight":0.1922},{"period":"6month","weight":0.0502},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.0708}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Albany Molecular Research, Inc.于1991年6月20日成立于特拉华州,是一家全球性的合同化研究制造组织。公司为客户提供全面整合的药物发明、开发、制造服务。AMRI提供广泛的服务和技术支持,包括医药产品的研发、现有和试验新药的原料药和成品药的生产。在美国、欧洲、亚洲均有分部,AMRI保持了和客户在地理上的密切接触以及灵活多变的成本模式。AMRI也历史性的利用其药物开发专业技术施行数个内部药物开发项目,这些项目已经进入候选研发状态,有一些甚至进入了第一期临床研发状态。AMRI已经成功完成一些项目的合作计划,并正在积极寻求与战略伙伴就剩余项目的对外授权事项做进一步发展。公司提供科学的服务、技术以及产品,致力于提高生活质量。公司核心业务为有包括药物研发、生产的合同服务费用平台。公司还拥有一系列从内部项目产生的专有技术,包括药物研发、小众市场产品和制造工艺效率改进,其中一些授权给第三方,有益于公司运作。","exchange":"NASDAQ","name":"奥尔巴尼","nameEN":"Albany Molecular Research"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AMRI\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMRI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-05-09","symbol":"AMRI","fiscalQuarterEnding":"2017/03","expectedEps":0.07,"name":null,"time":"盘前","type":"earning","dateTimestamp":1494302400000,"reportTimeType":"pre","actualEps":0.13},{"market":"US","date":"2017-02-21","symbol":"AMRI","fiscalQuarterEnding":"2016/12","expectedEps":0.48,"name":null,"time":"盘前","type":"earning","dateTimestamp":1487653200000,"reportTimeType":"pre","actualEps":0.3},{"market":"US","date":"2016-11-08","symbol":"AMRI","fiscalQuarterEnding":"2016/09","expectedEps":0.13,"name":null,"time":"盘前","type":"earning","dateTimestamp":1478581200000,"reportTimeType":"pre","actualEps":0.14},{"market":"US","date":"2016-08-04","symbol":"AMRI","fiscalQuarterEnding":"2016/06","expectedEps":0.33,"name":null,"time":"","type":"earning","dateTimestamp":1470283200000,"reportTimeType":"","actualEps":0.32},{"market":"US","date":"2016-05-10","symbol":"AMRI","fiscalQuarterEnding":"2016/03","expectedEps":0.21,"name":null,"time":"盘前","type":"earning","dateTimestamp":1462852800000,"reportTimeType":"pre","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMRI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMRI\",market:\"US\",delay:false,,,undefined,":{}}}